Found 41 matching trials
Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration
PHASE1The present study will be conducted in order to compare the bioavailability...
Location
SocraTec R&D GmbH Clinical Pharmacology Unit
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
N/APatients who have iron overload due to chronic blood transfusions and have ...
Status
Approved For Marketing
Location
The Children's Hospital of Philadelphia
Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
PHASE4Changes in chelation treatment and transfusion practices, during the past t...
A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
PHASE2The primary objective of this study is to evaluate the long-term safety and...
Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
PHASE2Patients who are genetically diagnosed with the recently reported and rare ...
Location
Hadassah medical center
A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment
EARLY_PHASE1The investigators propose to conduct a series of N of One (No1) single blin...
Location
University of Texas Health Science Center
Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients
EARLY_PHASE1Aceruloplasminemia is an autosomal recessive disorder characterized by iron...
Location
Department of Neurology , First Affiliated Hospital Fujian Medical University
Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects
PHASE4Randomized, single-dose, double-blind, placebo and active controlled, four-...
Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet
PHASE2Study to evaluate patient preference of deferasirox film-coated tablet (FCT...
Location
Novartis Investigative Site
A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
PHASE1The primary objective of this study is to demonstrate the safety and tolera...
Location
Murdoch Children's Research Institute